Clinical Trial

Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

Completed Phase 4
View on ClinicalTrials.gov →
Summary
Sufentanil-ropivacaine combination is commonly used for epidural labor anesthesia, but is associated with some adverse events. Dexmedetomidine and esketamine, each has been effectively used for neuraxial anesthesia in combination with local anesthetics. Plenty of evidences show that both dexmedetomidine and esketamine, combined with ropivacaine, are also effective as the sufentanil-ropivacaine combination when used for epidural labor analgesia. This pilot trial is designed to evaluate the efficacy and safety of the dexmedetomidine-esketamine-ropivacaine versus sufentanil-ropivacaine combination for epidural labor analgesia, and to test the feasibility of a future large randomized trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-27.
Status change: Not Yet Recruiting → Completed 2026-04-08
Trial Details
NCT Number NCT07145775
Lead Sponsor Peking University First Hospital
Conditions Epidural Analgesia, Labor Pain, Sufentanil, Dexmedetomidine, Esketamine, Ropivacaine
Enrollment 300 participants
Start Date 2025-09-05
Primary Completion 2026-01-29 (estimated)
Study Completion 2026-03-13 (estimated)
Updated on ClinicalTrials.gov 2026-04-13